JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 14, 2004; DOI: 10.1124/jpet.104.076836


0022-3565/05/3123-1151-1160$20.00
JPET 312:1151-1160, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.076836v1
312/3/1151    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paine, M. F.
Right arrow Articles by Watkins, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paine, M. F.
Right arrow Articles by Watkins, P. B.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Two Major Grapefruit Juice Components Differ in Time to Onset of Intestinal CYP3A4 Inhibition

Mary F. Paine, Anne B. Criss, and Paul B. Watkins

General Clinical Research Center (M.F.P., A.B.C., P.B.W.), Division of Pharmacotherapy (M.F.P., P.B.W.), and Department of Medicine (P.B.W.), University of North Carolina, Chapel Hill, North Carolina

Grapefruit juice elevates blood levels of some drugs taken orally, primarily by inhibiting intestinal CYP3A4-mediated first-pass metabolism. Two prominent furanocoumarins in the juice, 6',7'-dihydroxybergamottin (DHB) and bergamottin (BG), have been demonstrated as important contributors to grapefruit juice-drug interactions. Using CYP3A4-expressing Caco-2 cells and representative probes from distinct CYP3A4 substrate subgroups (midazolam, testosterone), we compared the time-dependent inhibitory properties of DHB and BG. DHB rapidly inhibited CYP3A4 activity in a substrate-independent fashion with maximal inhibition (≥85%) generally occurring within 30 min. In contrast, BG had a slower onset and exhibited substrate-dependent inhibition. Whereas testosterone 6{beta}-hydroxylation was inhibited by >50% with all exposure times (0.5-3 h), midazolam 1'-hydroxylation was unaffected, or even activated, with short exposure times (<1 h). After a 3-h exposure, however, BG had begun to "catch up" with DHB, causing ≥70% inhibition, independent of substrate. Likewise, loss of CYP3A4 protein, believed to reflect rapid intracellular degradation of the enzyme following mechanism-based inactivation, was comparable between the furanocoumarins (40-50%). The time course of BG-mediated inhibition was similar after just a 30-min exposure, indicating that the short exposure presumed to occur after juice ingestion is sufficient to initiate the events required to cause substantial inhibition (≥50%). These results suggest that after ingestion of a glass of grapefruit juice, CYP3A4 is maximally inhibited by DHB before BG has the opportunity to act. However, foods containing BG but not DHB (e.g., lime juice) could produce a substrate-dependent interaction with drugs consumed concomitantly, but a substrate-independent interaction with drugs taken several hours after food consumption.


Received August 28, 2004; accepted October 13, 2004.

Address correspondence to: Dr. Mary F. Paine, General Clinical Research Center, Room 3005 Bldg. APCF, CB# 7600, UNC Hospitals, Chapel Hill, NC 27599-7600. E-mail: mpaine{at}med.unc.edu




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. F Paine, W. W Widmer, S. N Pusek, K. L Beavers, A. B Criss, J. Snyder, and P. B Watkins
Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 863 - 871.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
D. Farkas, L. E. Oleson, Y. Zhao, J. S. Harmatz, M. A. Zinny, M. H. Court, and D. J. Greenblatt
Pomegranate Juice Does Not Impair Clearance of Oral or Intravenous Midazolam, a Probe for Cytochrome P450-3A Activity: Comparison With Grapefruit Juice
J. Clin. Pharmacol., March 1, 2007; 47(3): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Larbat, S. Kellner, S. Specker, A. Hehn, E. Gontier, J. Hans, F. Bourgaud, and U. Matern
Molecular Cloning and Functional Characterization of Psoralen Synthase, the First Committed Monooxygenase of Furanocoumarin Biosynthesis
J. Biol. Chem., January 5, 2007; 282(1): 542 - 554.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Y. Liu, J.-W. Zhang, W. Li, H. Ma, J. Sun, M.-C. Deng, and L. Yang
Ginsenoside Metabolites, Rather Than Naturally Occurring Ginsenosides, Lead to Inhibition of Human Cytochrome P450 Enzymes
Toxicol. Sci., June 1, 2006; 91(2): 356 - 364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F Paine, W. W Widmer, H. L Hart, S. N Pusek, K. L Beavers, A. B Criss, S. S Brown, B. F Thomas, and P. B Watkins
A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction
Am. J. Clinical Nutrition, May 1, 2006; 83(5): 1097 - 1105.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.